Biogen (BIIB)

Cash & Short-Term Investments

$1.29B

Quarterly · Period ending: · USD

BIIB logo

BIIB Cash & Short-Term Investments

Latest reported$3.82B
BIIB FY Cash & Short-Term Investments ($53.50M → $3.82B)
High-resolution chart · PNG

BIIB cash & short-term investments history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Biogen Cash & Short-Term Investments — Annual fiscal periods (USD)
Period endingCash & Short-Term Investments (USD)
3,815,700,000
2,375,000,000
1,049,900,000
4,892,800,000
3,802,500,000
2,610,100,000
4,475,900,000
3,538,000,000
3,689,000,000
4,895,100,000
3,428,500,000
1,845,384,000
1,222,729,000
1,705,710,000
1,690,657,000
1,207,744,000
1,263,724,000
1,371,417,000
1,183,503,000
902,691,000
850,753,000
1,057,942,000
835,959,000
867,109,000
798,107,000
682,412,000
654,539,000
516,914,000
440,088,000
321,381,000
307,948,000
267,802,000
74,500,000
85,900,000
56,600,000
12,600,000
33,200,000
54,300,000
54,400,000
70,500,000
53,500,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.